arrow
B

Benjamín Rossi

hopital universitaire avicenne - aphp
H指数:22
被引数:3,513

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Targeting BCMA in multiple myeloma with a trifunctional NK cell engager

以三功能NK细胞接合剂靶向多发性骨髓瘤中的BCMA

2026-02-170
OAAI
Comparing diagnostic methods for historical arbovirus outbreaks: Insights from 19th century dengue epidemics

比较历史蚊媒病毒爆发中的诊断方法:来自19世纪登革热大流行的见解

2025-09-260
PRE
Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing

全基因组CRISPR/Cas9筛选揭示了影响肿瘤细胞对NK细胞介导杀伤易感性的因素

2025-03-310
OA
A tetraspecific engager armed with a non-alpha IL-2 variant harnesses natural killer cells against B cell non-Hodgkin lymphoma
2024-11-151
PRE
Preclinical characterization of IPH45, a novel topoisomerase I inhibitor ADC targeting Nectin-4 for the treatment of Nectin-4 expressing tumors
2024-03-222
PRE
The novel trifunctional anti-BCMA NK cell engager SAR'514 has potent in-vitro, in-vivo and ex-vivo anti-myeloma effect through dual NK cell engagement
2023-04-040
PRE
Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

通过靶向CD123的三功能NKp46-CD16a-NK细胞接合器控制急性髓系白血病

2023-01-1248
OAAI
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant
2022-10-0144
OAAI
Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies
2019-05-01347
OAAI
Preclinical development of humanized CD39 and CD73 blocking antibodies targeting the ATP/adenosine immune checkpoint pathway for cancer immunotherapy
2018-07-013
PRE